Auteurs
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration sur les peptides biopesticides - Exploration (Accueil)

Index « Auteurs » - entrée « Peter R. Flatt »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Peter Nollau < Peter R. Flatt < Peter R. Judzewitsch  Facettes :

List of bibliographic references indexed by Peter R. Flatt

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000112 (2020) Ryan A. Lafferty [Royaume-Uni] ; Neil Tanday [Royaume-Uni] ; Peter R. Flatt [Royaume-Uni] ; Nigel Irwin [Royaume-Uni]Development and characterisation of a peptidergic N-and C-terminally stabilised mammalian NPY1R agonist which protects against diabetes induction.
001F40 (2013) Christine M A. Martin [Royaume-Uni] ; Nigel Irwin ; Peter R. Flatt ; Victor A. GaultA novel acylated form of (d-Ala(2))GIP with improved antidiabetic potential, lacking effect on body fat stores.
002557 (2011) Victor A. Gault [Royaume-Uni] ; David W. Porter ; Nigel Irwin ; Peter R. FlattComparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed mice.
003033 (2007) Nigel Irwin [Royaume-Uni] ; Paula L. Mcclean ; Roslyn S. Cassidy ; Finbarr P M. O'Harte ; Brian D. Green ; Victor A. Gault ; Patrick Harriott ; Peter R. FlattComparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide.
003203 (2006) Brian D. Green [Royaume-Uni] ; Peter R. Flatt ; Clifford J. BaileyInhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes.
003204 (2006) Brian D. Green [Royaume-Uni] ; Nigel Irwin ; Nicola A. Duffy ; Victor A. Gault ; Finbarr P M. O'Harte ; Peter R. FlattInhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
003241 (2006) Brian D. Green [Royaume-Uni] ; Peter R. Flatt ; Clifford J. BaileyDipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes.
003537 (2004) Brian D. Green [Royaume-Uni] ; Victor A. Gault ; Finbarr P M. O'Harte ; Peter R. FlattStructurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Peter R. Flatt" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Peter R. Flatt" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Peter R. Flatt
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020